SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-15-050163
Filing Date
2015-02-13
Accepted
2015-02-13 16:35:53
Documents
1
Group Members
JACOB GOTTLIEBJG ASSET, LLCVISIUM BALANCED MASTER FUND, LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d873860dsc13ga.htm SC 13G/A 97508
  Complete submission text file 0001193125-15-050163.txt   99405
Mailing Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS BLDG., SUITE 290 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4401 RESEARCH COMMONS BLDG., SUITE 290 RESEARCH TRIANGLE PARK NC 27709 (609) 986-1780
NephroGenex, Inc. (Subject) CIK: 0001338095 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88014 | Film No.: 15615339
SIC: 2834 Pharmaceutical Preparations

Mailing Address 888 SEVENTH AVENUE - 22ND FLOOR NEW YORK NY 10019
Business Address 888 SEVENTH AVENUE - 22ND FLOOR NEW YORK NY 10019 212-474-8800
Visium Asset Management, LP (Filed by) CIK: 0001377452 (see all company filings)

IRS No.: 203313013 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A